Diiron μ-aminocarbyne compounds, 1a-e, are prepared in two steps from Fe 2 Cp 2 (CO) 4 , negating the need for difficult purification procedures of intermediate species; they are efficiently isolated by alumina chromatography. Minor amounts of μ-aminocarbyne aryl isocyanide compounds, 2a-c, are obtained as side products. The structures of the cations in 1a,c,e are calculated using DFT; the carbyne carbon is generally predicted to be the thermodynamic site of hydride addition, in agreement with a previous experimental finding concerning 1a. Accordingly, the reaction of 1e with NaBH 4 affords a bridging aminocarbene complex, 4, in 85 % yield. Otherwise, the reaction of 1c with NaBH 4 yields the aminocarbyne-cyclopentadiene derivative 3 (70 %), presumably as a consequence of the [a] Scheme 1. Regioselective additions of nucleophiles to the diiron aminocarbyne complex 1a. Results and DiscussionThe commercial compound [Fe 2 Cp 2 (CO) 4 ] was reacted with the appropriate isocyanide, in a ca. 3:2 molar ratio, in acetonitrile solution. [16] The reactions with alkyl isocyanides were conducted under reflux conditions, whereas the reactions with aryl isocyanides proceeded at room temperature. The resulting mixtures were dried under vacuum and the residues were dissolved in dichloromethane and then treated with methyl triflate, thus affording the μ-aminocarbyne complexes 1a-e (Scheme 2). The difficult isolation of the monoisocyanide intermediates (see the Introduction) was unnecessary. The final products 1a-e were efficiently purified by alumina chromatography and were then isolated as microcrystalline, air-stable compounds in 65-92 % yields. The synthesis of 1c-e was accompanied by the side formation of minor products derived from di-isocyanide species, 2a-c. Compounds 2a-c were recovered by the chromatography in 3-12 % yields, although 2a was formerly reported as being Scheme 2. Synthesis of diiron μ-aminocarbyne complexes.Eur. J. Inorg. Chem. 2018, 960-971 www.eurjic.org

Although ferrocene derivatives have attracted considerable attention as possible anticancer agents, the medicinal potential of diiron complexes has remained largely unexplored. Herein, we describe the straightforward multigram‐scale synthesis and the antiproliferative activity of a series of diiron cyclopentadienyl complexes containing bridging vinyliminium ligands. IC50 values in the low‐to‐mid micromolar range were determined against cisplatin sensitive and resistant human ovarian carcinoma (A2780 and A2780cisR) cell lines. Notable selectivity towards the cancerous cells lines compared to the non‐tumoral human embryonic kidney (HEK‐293) cell line was observed for selected compounds. The activity seems to be multimodal, involving reactive oxygen species (ROS) generation and, in some cases, a fragmentation process to afford monoiron derivatives. The large structural variability, amphiphilic character and good stability in aqueous media of the diiron vinyliminium complexes provide favorable properties compared to other widely studied classes of iron‐based anticancer candidates.

The synthesis and characterization of hitherto hypothetical AuIII π‐alkyne complexes is reported. Bonding and stability depend strongly on the trans effect and steric factors. Bonding characteristics shed light on the reasons for the very different stabilities between the classical alkyne complexes of PtII and their drastically more reactive AuIII congeners. Lack of back‐bonding facilitates alkyne slippage, which is energetically less costly for gold than for platinum and explains the propensity of gold to facilitate C−C bond formation. Cycloaddition followed by aryl migration and reductive deprotonation is presented as a new reaction sequence in gold chemistry.

A series of diiron complexes based on the [Fe2Cp2(CO) x ] skeleton (Cp = η5-C5H5, x = 2, 3; η4-C5H5Ph in place of one Cp in one case) and containing different bridging hydrocarbyl ligands (aminocarbyne, thiocarbyne, allenyl) were preliminarily investigated for their anticancer potential. The water solubility, stability in water and in the presence of a cell culture medium, and octanol/water partition coefficient were evaluated by spectroscopic techniques. The cytotoxicity was assessed in vitro toward the human ovarian carcinoma cell line A2780, the human triple negative breast cancer cell line MDA-MB-231, and the human vascular smooth muscle cell line SMC. Some aminocarbyne complexes exhibited a potent cytotoxicity, with IC50 values in the low micromolar/nanomolar range, and a strong selectivity for the A2780 cells in comparison to the SMC cell line. Several experiments were carried out in order to give insight into the mode of action of selected compounds, including an assessment of catalytic NADH oxidation and ROS production and studies of binding with DNA and with a model protein.

Pyridine- and phosphine-based ligands modified with ethacrynic acid (a broad acting glutathione transferase inhibitor) were prepared and coordinated to ruthenium(II)-arene complexes and to a ruthenium(III) NAMI-A type complex. All the compounds (ligands and complexes) were fully characterized by analytical and spectroscopic methods and, in one case, by single-crystal X-ray diffraction. The in vitro anticancer activity of the compounds was studied, with the compounds displaying moderate cytotoxicity toward the human ovarian cancer cell lines. All the complexes led to similar levels of residual GST activity in the different cell lines, irrespective of the stability of the Ru-ligand bond.

A series of diiron/tetrairon compounds containing a S- or a Se-function (2a–d, 4a–d, 5a–b, 6), and the monoiron [FeCp(CO){SeC1(NMe2)C2HC3(Me)}] (3) were prepared from the diiron μ-vinyliminium precursors [Fe2Cp2(CO)( μ-CO){μ-η1: η3-C3(R’)C2HC1N(Me)(R)}]CF3SO3 (R = R’ = Me, 1a; R = 2,6-C6H3Me2 = Xyl, R’ = Ph, 1b; R = Xyl, R’ = CH2OH, 1c), via treatment with S8 or gray selenium. The new compounds were characterized by elemental analysis, IR and multinuclear NMR spectroscopy, and structural aspects were further elucidated by DFT calculations. The unprecedented metallacyclic structure of 3 was ascertained by single crystal X-ray diffraction. The air-stable compounds (3, 4a–d, 5a–b, 6) display fair to good stability in aqueous media, and thus were assessed for their cytotoxic activity towards A2780, A2780cisR, and HEK-293 cell lines. Cyclic voltammetry, ROS production and NADH oxidation studies were carried out on selected compounds to give insights into their mode of action.

The one-electron reduction of a diiron cationic complex revealed unique features: cleavage of the diiron structure occurred despite a multidentate bridging C3 ligand and was accompanied by the clean dissociation of one η5-cyclopentadienyl ring and one iron as isolated units. Thus, the iron­(II)–iron­(II) μ-vinyliminium complex [Fe2Cp2(CO)­(μ-CO)­{μ-η1:η3-C3(Et)­C2HC1N­(Me)­(Xyl)}]­[SO3CF3] ([1a]­SO3CF3) reacted with cobaltocene in tetrahydrofuran (THF), affording the iron­(II) vinylaminoalkylidene [FeCp­(CO)­{C1N­(Me)­(Xyl)­C2HC3(Et)­C­(O)}] (2a) in 77% yield relative to the C3 ligand. Analogously, [FeCp­(CO)­{C1N­(Me)­(Xyl)­C2HC3(CH2OH)­C­(O)}] (2b) was obtained in 64% yield from the appropriate diiron precursor and CoCp2. The formation of 2a is initiated by the one-electron reduction of [1a]+, followed by a reversible intramolecular rearrangement terminating with the irreversible release of CpH (NMR and gas chromatography–mass spectrometry) and Fe [electron paramagnetic resonance (EPR) and magnetometry]. The key intermediate iron­(I) ferraferrocene (3) was detected by EPR and IR spectroelectrochemistry, while the related species 3-H-3 was isolated after the addition of a hydrogen source and then identified by X-ray diffraction. A plausible mechanism for the route from [1a]+ to 3 was ascertained by density functional theory calculations. The dication [1a]2+, displaying both carbonyl ligands in terminal positions, and the anion [3]− were electrochemically generated. The functionalized diiron compounds 4 (52% yield) and 5 (62%) were afforded through the activation of O2 and S8 by a radical intermediate along the reductive pathway of [1a]+. The reaction of [Fe2Cp2(CO)­(μ-CO)­{μ-η1:η3-C­(SiMe3)­CHCN­(Me)­(Xyl)}]­[SO3CF3] ([1c]­SO3CF3) with CoCp2 in THF afforded [Fe2Cp2(CCSiMe3)­(CO)­(μ-CO)­{μ-CNMe­(Xyl)}] (6) in 65% yield.

In this work, a commercial SBS was functionalized with the 2,2,6,6-tetramethylpiperidin-N-oxyl stable radical (TEMPO) via free-radical activation initiated with benzoyl peroxide (BPO). The obtained macroinitiator was used to graft both vinylbenzyl chloride (VBC) and styrene/VBC random copolymer chains from SBS to create g-VBC-x and g-VBC-x-co-Sty-z graft copolymers, respectively. The controlled nature of the polymerization as well as the use of a solvent allowed us to reduce the extent of the formation of the unwanted, non-grafted (co)polymer, thereby facilitating the graft copolymer’s purification. The obtained graft copolymers were used to prepare films via solution casting using chloroform. The –CH2Cl functional groups of the VBC grafts were then quantitatively converted to –CH2(CH3)3N+ quaternary ammonium groups via reaction with trimethylamine directly on the films, and the films, therefore, were investigated as anion exchange membranes (AEMs) for potential application in a water electrolyzer (WE). The membranes were extensively characterized to assess their thermal, mechanical, and ex situ electrochemical properties. They generally presented ionic conductivity comparable to or higher than that of a commercial benchmark as well as higher water uptake and hydrogen permeability. Interestingly, the styrene/VBC-grafted copolymer was found to be more mechanically resistant than the corresponding graft copolymer not containing the styrene component. For this reason, the copolymer g-VBC-5-co-Sty-16-Q with the best balance of mechanical, water uptake, and electrochemical properties was selected for a single-cell test in an AEM-WE.